Log in to save to my catalogue

HDL-targeted therapies: progress, failures and future

HDL-targeted therapies: progress, failures and future

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1658764168

HDL-targeted therapies: progress, failures and future

About this item

Full title

HDL-targeted therapies: progress, failures and future

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Drug discovery, 2014-06, Vol.13 (6), p.445-464

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Key Points
The association of low plasma high-density lipoprotein cholesterol (HDL-C) concentration with elevated cardiovascular disease risk is firmly established in men and women over a wide age range, across several cardiometabolic disease states, including type 2 diabetes, and in many populations and ethnic groups.
These associations unde...

Alternative Titles

Full title

HDL-targeted therapies: progress, failures and future

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1658764168

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1658764168

Other Identifiers

ISSN

1474-1776

E-ISSN

1474-1784

DOI

10.1038/nrd4279

How to access this item